Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-125717
Filing Date
2024-11-12
Accepted
2024-11-12 17:47:55
Documents
1
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6081
  Complete submission text file 0000950170-24-125717.txt   7644
Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40708 | Film No.: 241450214

Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Issuer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)